MY-ENDO -- Mind Your ENDOmetriosis: a Digital Mindfulness- and Acceptance-based Endometriosis Self-management Program
Launched by UNIVERSITY OF AARHUS · Jan 8, 2024
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
The MY-ENDO trial is studying how a digital program focused on mindfulness and acceptance can help women with endometriosis improve their quality of life. Endometriosis is a condition that can cause chronic pain, fatigue, and a lower quality of life. This program aims to see if practicing mindfulness and yoga at home for about 30-45 minutes each day can help participants feel better physically and mentally, as well as improve their work ability and pain experiences.
To be eligible for this trial, participants must be at least 18 years old and have a diagnosis of endometriosis confirmed by a healthcare professional. They should be experiencing moderate to severe pelvic pain or fatigue, and have tried previous treatments for endometriosis. Participants will be expected to engage in mindfulness practices regularly during the study. It's important to note that individuals with severe psychiatric conditions, those who are pregnant, or those facing major life challenges may not be eligible to join. This trial is currently looking for participants, and taking part could provide valuable support for managing endometriosis symptoms.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • ≥18 years old.
- • Signed informed consent.
- • Endometriosis diagnosed by a gynecologist based on the medical case history, ultrasound, laparoscopy, or MRI (all self-reported).
- * Moderate to severe symptoms (pelvic pain and/or fatigue measured on an 11-point numeric rating scale (NRS) from 0 = no pain/fatigue to 10 = worst imaginable pain/fatigue symptom) or reduced endometriosis-related quality of life (measured by the EHP-30):
- • Moderate to severe endometriosis-related chronic pelvic pain (NRS \> 2) or
- • Moderate to severe endometriosis-related fatigue (NRS \> 2) or
- • Low endometriosis-related quality of life (one or more EHP-30 subscale mean scores ≥ 40.00).
- • Relevant clinical and/or surgical treatment according to the European Society of Human Reproduction and Embryology (ESHRE) guidelines for endometriosis has been attempted.
- • Willingness to practice mindfulness and yoga at home for 30-45 minutes 5-7 days a week during the treatment period.
- Exclusion Criteria:
- • Under 18 years old.
- • Severe psychiatric diagnosis made by a psychiatrist and/or ongoing psychiatric treatment.
- • Pregnancy or planned pregnancy during the study period.
- * An estimated lack of capacity or surplus energy to enter into a digital mindfulness treatment, for instance, because of:
- • major life events taking place at the same time (e.g., divorce, loss of a close relative, etc.)
- • linguistic or cultural barriers
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus, Central Jutland Region, Denmark
Billund, , Denmark
Patients applied
Trial Officials
Henrik Marschall, MSc
Principal Investigator
University of Aarhus
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported